Ethos Financial Group’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-252	Closed	-$265K	–	418
2024 Q3	$265K	Buy	252 +11	+5%	+$11.6K	0.04%	225
2024 Q2	$267K	Buy	+241	New	+$267K	0.05%	219